Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Scattering acquisitions nationwide creates operational strain across distinct legal environments. Grouping practices into regional hubs, such as the Pacific Northwest and Southern California, establishes operational focus and manageable scale before entering new territories.

Related Insights

Successful serial acquirers like Comfort Systems often employ a decentralized structure. This empowers the management of acquired companies, who are closer to the customers, to make operational decisions, fostering autonomy and better local market adaptation.

When scaling, the firm chose Europe as its first growth vector because it allowed them to replicate their exact strategy in the same industries and check sizes. This approach minimizes strategic variables, viewing geography as the most "close in adjacent" move before tackling different deal sizes or verticals, ensuring operational consistency.

In states enforcing the corporate practice of medicine doctrine, non-physician investors cannot directly own medical practices. Setting up a management services organization tied to physician-owned professional LLCs via master services agreements sweeps economic cash flows to investors while ensuring compliance across strict jurisdictions.

Classifying acquisition targets into three tiers—Hubs (new regions with strong management), Spokes (smaller tuck-ins), and Route Buys (customer lists)—creates a disciplined strategy. This ensures each acquisition serves a specific, pre-defined purpose in the overall consolidation and has a corresponding deal structure.

When scaling a local service business like a chiropractic office, acquiring existing practices is a more efficient growth path than building new ones from scratch. It's often possible to find owners willing to sell for very little, making it easier to retrofit them into your model.

Instead of opening franchises in distant locations, a new franchisor should first build 5-10 locations within a few hours' drive. This strategy, used by successful franchises like Orangetheory, allows for better oversight, support, and testing of the model before a national rollout.

The field of ophthalmology is particularly well-suited for a hub-and-spoke model because it utilizes a wide range of treatment modalities (small molecules, biologics, devices, gene therapy). This allows a central hub to leverage shared expertise in areas like ocular delivery and regulatory pathways across multiple, diverse spokes.

For buy-and-build firms, speed is a defensive necessity. A single acquired asset carries significant micro-market risks, like customer concentration. Rapidly consolidating multiple units diversifies these specific risks, stabilizing the entire platform and making it more resilient.

Although pressure for deal volume is high, successful roll-ups leave room in year one to build a solid foundation. This includes refining the playbook, systems, and processes needed to scale effectively, ensuring long-term success over short-term numbers.

Scaling complex cell therapies follows a similar trajectory to monoclonal antibodies. The strategy involves establishing a global footprint with regional manufacturing facilities (e.g., US West, US East, Europe) to serve distinct geographic areas. This approach ensures manageable logistics and reliable delivery for personalized medicines, leveraging historical lessons.